申请人:CELLTECH THERAPEUTICS LIMITED
公开号:EP0382583A1
公开(公告)日:1990-08-16
Aza macrocycles of the formula (1)
wherein
A is a group -(CH₂)p- or -(CH₂)p N(R)(CH₂)q- where R is a group -CH(R⁴)X⁴;
m, n, p, and q, which may be the same or different, is each an integer 2 or 3;
R¹, R², R³ and R⁴, which may be the same or different, is each a group -CO₂H, -P(R⁵)O₂H (where R⁵ is a hydrogen atom or an alkyl or alkoxy group), -PO₃H₂ or -CONR⁶R⁷ (where R⁶ and R⁷, which may be the same or different is each a hydrogen atom or an alkyl group);
X¹, X², X³ and X⁴, which may be the same or different, is each a hydrogen atom or an alkyl group, or a linker group, with the proviso that at least one of X¹, X², X³ or X⁴ is a linker group; and protected derivatives and metal complexes and/or salts thereof; are described together with processes for their preparation and compositions containing them. The compounds are useful for imaging and in the treatment of abnormal cell disorders, such as in the treatment of tumours, and may be coupled to other molecules such as proteins for use in diagnosis and therapy.
式(1)的氮杂大环
其中
A 是基团 -(CH₂)p- 或 -(CH₂)p N(R)(CH₂)q- 其中 R 是基团 -CH(R⁴)X⁴;
m、n、p 和 q(可以相同或不同)均为 2 或 3 的整数;
R¹、R²、R³ 和 R⁴(可以相同或不同)各自是基团 -CO₂H、-P(R⁵)O₂H(其中 R⁵ 是氢原子或烷基或烷氧基)、-PO₃H₂或-CONR⁶R⁷(其中 R⁶ 和 R⁷ 可以相同或不同,各自为氢原子或烷基);
X¹、X²、X³和 X⁴(可以相同或不同)各自是氢原子或烷基或连接基,但 X¹、X²、X³或 X⁴ 中至少有一个是连接基;以及受保护的衍生物和金属配合物和/或其盐;这些化合物连同其制备工艺和含有它们的组合物一起进行了描述。这些化合物可用于成像和异常细胞疾病的治疗,如肿瘤的治疗,也可与其他分子如蛋白质结合用于诊断和治疗。